Drug data last refreshed 5h ago · AI intelligence enriched 1w ago
Loratadine is an oral antihistamine suspension approved for treating allergic conditions. It is a selective peripheral H1-receptor antagonist that provides non-sedating relief from allergy symptoms. This generic formulation is widely used across patient populations with seasonal and perennial allergies.
As a mature generic with approaching LOE and moderate competitive pressure (30%), the brand team is likely focused on cost optimization and market defense rather than expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu
A Study to Learn What Participants Think of Treatment With Betamethasone Plus Loratadine to Treat Their Acute Allergic Rhinitis, Also Known as Hay Fever in Mexico
A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure
A Study to Assess the Bioequivalence of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared With Clarityne Tablets
A Study to Assess the Relative Bioavailability of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared to Clarityne Tablets
Worked on LORATADINE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on loratadine offers limited career growth potential given its mature, generic market status and approaching LOE. Positions on this product are typically focused on cost containment, supply chain efficiency, and defensive market strategy rather than innovation or expansion.